This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
SALEM – Proponents expect a bill that would force prescription drug manufacturers to be more transparent about price hikes to land soon on Gov. Kate Brown’s desk, putting Oregon at the forefront of efforts to fight against skyrocketing drug prices.
Oregon has agreed to settle with the pharmaceutical company, Pfizer, again over false, misleading or illegal marketing claims or promotions of its drugs.
California Gov. Gavin Newsom says he’s done waiting for the federal government to curtail the rising cost of prescription drugs.
Newsom has his own plan to ease that financial burden — one he hopes other states can join or replicate.
Medicare patients with multiple sclerosis face skyrocketing costs for treatment due to insurance regulations that force them to pay more out of pocket for generic drugs, a study has found.
President Donald Trump’s new pledge to crack down on “the global freeloading” in prescription drugs had a sense of déjà vu.
For years, most pharmacists couldn’t give customers even a clue about an easy way to save money on prescription drugs. But the restraints are coming off.
Three months after President Donald Trump announced his blueprint to bring down drug prices, administration officials have begun putting some teeth behind the rhetoric.
Oregon U.S. Sen. Ron Wyden again blasted the Trump administration on Monday over its proposed drug pricing plan.
Rep. Rob Nosse, D-Portland, touted his aggressive and innovative approach to tackling uncontrolled pharmaceutical costs on Thursday, calling on Oregon to lead where Congress has failed and other state-based reforms have fallen short.